Zobrazeno 1 - 10
of 470
pro vyhledávání: '"Nina Langeland"'
Autor:
Getnet Tesfaw, Dawd S. Siraj, Alemseged Abdissa, Rasmus Riemer Jakobsen, Øystein H. Johansen, Mike Zangenberg, Kurt Hanevik, Zeleke Mekonnen, Nina Langeland, Ola Bjørang, Nasia Safdar, Abigail C. Mapes, Ashley Kates, Lukasz Krych, Josué L. Castro-Mejía, Dennis S. Nielsen
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-15 (2024)
Abstract Diarrhea claims >500,000 lives annually among children under five years of age in low- and middle-income countries. Mortality due to acute diarrhea (
Externí odkaz:
https://doaj.org/article/d145a02bba3d402385a9ee13b54f06fc
Autor:
Geir Bredholt, Marianne Sævik, Hanne Søyland, Thor Ueland, Fan Zhou, Rishi Pathirana, Anders Madsen, Juha Vahokoski, Sarah Lartey, Bente E. Halvorsen, Tuva B. Dahl, Mai-Chi Trieu, Kristin G.-I. Mohn, Karl Albert Brokstad, Pål Aukrust, Camilla Tøndel, Nina Langeland, Bjørn Blomberg, Rebecca Jane Cox
Publikováno v:
Vaccine: X, Vol 20, Iss , Pp 100564- (2024)
Objectives: Booster COVID-19 vaccinations are used to protect the elderly, a group vulnerable to severe disease. We compared humoral and cellular immunity in older versus younger adults up to eight months after administering a BNT16b2 booster vaccine
Externí odkaz:
https://doaj.org/article/97a58f3486274e709a8a91d0108e5ba7
Publikováno v:
npj Vaccines, Vol 9, Iss 1, Pp 1-9 (2024)
Abstract The endemic human coronaviruses (HCoVs) circulate worldwide yet remain understudied and unmitigated. The observation of elevated levels of HCoV reactive antibodies in COVID-19 patients highlights the urgent necessity of better understanding
Externí odkaz:
https://doaj.org/article/d506bb46c518425ba1a921e7705c0073
Autor:
Annette Onken, Sabrina Moyo, Mohammed Khamis Miraji, Jon Bohlin, Msafiri Marijani, Joel Manyahi, Kibwana Omar Kibwana, Fredrik Müller, Pål A Jenum, Khamis Ali Abeid, Marianne Reimers, Nina Langeland, Kristine Mørch, Bjørn Blomberg
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 18, Iss 4, p e0012132 (2024)
BackgroundTyphoid fever is a common cause of febrile illness in low- and middle-income countries. While multidrug-resistant (MDR) Salmonella Typhi (S. Typhi) has spread globally, fluoroquinolone resistance has mainly affected Asia.MethodsConsecutivel
Externí odkaz:
https://doaj.org/article/06ff0241f1714ce891d38b403ff68736
Autor:
Arild Iversen, Bjørn Blomberg, Kjell Haug, Bård Kittang, Türküler Özgümüs, Rebecca Jane Cox, Nina Langeland
Publikováno v:
Frontiers in Public Health, Vol 12 (2024)
IntroductionA substantial proportion of the over 700 million COVID-19 cases world-wide experience long-term symptoms. The objectives of this study were to compare symptom trajectories and risk factors for post-COVID-19 condition after Delta and Omicr
Externí odkaz:
https://doaj.org/article/d114ad8da068431dbaa5386f2df7bafd
Autor:
Upendo O. Kibwana, Joel Manyahi, Sabrina J. Moyo, Bjørn Blomberg, Adam P. Roberts, Nina Langeland, Stephen E. Mshana
Publikováno v:
Frontiers in Tropical Diseases, Vol 5 (2024)
BackgroundEnterococci are becoming clinically more important especially among immunocompromised patients. Of concern are vancomycin resistant enterococci (VRE) which have both intrinsic and acquired forms of resistance. This work aimed to determine t
Externí odkaz:
https://doaj.org/article/b5c404fe450143ff86813022b4468cc7
Autor:
Christina S. Saghaug, Astrid L. Gamlem, Kirsti B. Hauge, Juha Vahokoski, Christian Klotz, Toni Aebischer, Nina Langeland, Kurt Hanevik
Publikováno v:
International Journal for Parasitology: Drugs and Drug Resistance, Vol 21, Iss , Pp 51-60 (2023)
The effectiveness of metronidazole against the tetraploid intestinal parasite Giardia lamblia is dependent on its activation/inactivation within the cytoplasm. There are several activating enzymes, including pyruvate ferredoxin reductase (PFOR) and n
Externí odkaz:
https://doaj.org/article/3c00945d5be44fffa805e8ddfa90d28c
Autor:
Upendo O. Kibwana, Joel Manyahi, Helene Heitmann Sandnes, Bjørn Blomberg, Stephen E. Mshana, Nina Langeland, Adam P. Roberts, Sabrina J. Moyo
Publikováno v:
BMC Infectious Diseases, Vol 23, Iss 1, Pp 1-13 (2023)
Abstract Background Fluoroquinolones have been, and continue to be, routinely used for treatment of many bacterial infections. In recent years, most parts of the world have reported an increasing trend of fluoroquinolone resistant (FQR) Gram-negative
Externí odkaz:
https://doaj.org/article/a37cd29817174fcb814648e1c0feaae9
Autor:
Therese Bredholt Onyango, Fan Zhou, Geir Bredholt, Karl A. Brokstad, Sarah Lartey, Kristin G.-I. Mohn, Türküler Özgümüs, Bård Reiakvam Kittang, Dagrun Waag Linchausen, Shahin Shafiani, Rebecca Elyanow, Bjørn Blomberg, Nina Langeland, Rebecca Jane Cox, Bergen COVID-19 Research Group, Amit Bansal, Anders Madsen, Camilla Tøndel, Elisabeth Berg Fjelltveit, Hanne Søyland, Helene Heitmann Sandnes, Jan Stefan Olofsson, Juha Vahokoski, Kristin Risa, Lena Hansen, Mai-Chi Trieu, Marianne Sævik, Nina Urke Ertesvåg
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Obesity is a known risk factor for severe respiratory tract infections. In this prospective study, we assessed the impact of being obese or overweight on longitudinal SARS-CoV-2 humoral and cellular responses up to 18 months after infection. 274 pati
Externí odkaz:
https://doaj.org/article/ef3b73d1559d4f2fb387d0dd4a40d9c4
Publikováno v:
Annals of Clinical Microbiology and Antimicrobials, Vol 22, Iss 1, Pp 1-7 (2023)
Abstract Background Over one million yearly deaths are attributable to Streptococcus pneumoniae and people living with HIV are particularly vulnerable. Emerging penicillin non-susceptible Streptococcus pneumoniae (PNSP) challenges therapy of pneumoco
Externí odkaz:
https://doaj.org/article/bd8bc71e6e7f47a29b2fce04b08c049e